Krispy Kreme reports massive Q2 loss, triggering a turnaround plan focused on cost reduction and operational efficiency.
Lilly's oral weight loss pill trails rivals in efficacy, faces market delay due to tolerability concerns.
Decades after 9/11, advanced DNA testing identifies three more victims, providing closure to families and highlighting the role of science in honoring the tragedy's victims.
Krispy Kreme reports massive Q2 loss, triggering a turnaround plan focused on cost reduction and operational efficiency.
Lilly's oral weight loss pill trails rivals in efficacy, faces market delay due to tolerability concerns.
Decades after 9/11, advanced DNA testing identifies three more victims, providing closure to families and highlighting the role of science in honoring the tragedy's victims.